Bionano Genomics, Inc. Warrant
BNGOW
BNGOW was delisted on the 17th of August, 2023.
2 hedge funds and large institutions have $277K invested in Bionano Genomics, Inc. Warrant in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
16% less capital invested
Capital invested by funds: $330K → $277K (-$53K)
33% less funds holding
Funds holding: 3 → 2 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AWM
Avior Wealth Management
Omaha,
Nebraska
|
-$2K |
BNGOW Hedge Fund Activity: Q2 2021 in Review
2 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics, Inc. Warrant (BNGOW) for Q2 2021, worth a combined $277K — down 16% from $330K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of BNGOW and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Avior Wealth Management, exiting entirely with an estimated $2K sold.
- 2 institutional investors held Bionano Genomics, Inc. Warrant (BNGOW) as of Q2 2021, down from 3 in Q1 2021.
- Funds reported $277K of Bionano Genomics, Inc. Warrant stock for Q2 2021, down 16% quarter-over-quarter.
- 0 funds opened new Bionano Genomics, Inc. Warrant positions in Q2 2021 and 1 closed out, a net change of -1 holder.
- The largest Bionano Genomics, Inc. Warrant seller in Q2 2021 was Avior Wealth Management, an estimated $2K sold.
Based on aggregated 13F filings for Q2 2021.